The short version
25 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Potassium Chloride · POTASSIUM CHLORIDE 1500 mg/1 · Tablet, Extended Release · Oral · Zydus Pharmaceuticals (USA) Inc.
NDC 68382-0740-01 · 100 TABLET, EXTENDED RELEASE in 1 BOTTLE · ANDA · View full market →
25 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Matched to CMS's representative package for this drug (NDC 00245-5319-11) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
OAI inspection at a producing facility (24 months) · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| A-S Medication Solutions | POTASSIUM CHLORIDE 1500 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Aphena Pharma Solutions - Tennessee, LLC | POTASSIUM CHLORIDE 750 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Bryant Ranch Prepack | POTASSIUM CHLORIDE 750 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Redpharm Drug | POTASSIUM CHLORIDE 1500 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Remedyrepack Inc. | POTASSIUM CHLORIDE 750 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Upsher-Smith Laboratories, LLC | POTASSIUM CHLORIDE 750 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Actavis Pharma, Inc. | POTASSIUM CHLORIDE 20 meq/1 | Jul 15, 2026 | Sep 2, 2026 |
| Adare Pharmaceuticals Inc | POTASSIUM CHLORIDE 1500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Adare Pharmaceuticals Inc | POTASSIUM CHLORIDE 10 meq/10meq | Jul 15, 2026 | Sep 2, 2026 |
| Advagen Pharma Ltd. | POTASSIUM CHLORIDE 750 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Advagen Pharma Ltd. | POTASSIUM CHLORIDE 1125 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Advagen Pharma Ltd. | POTASSIUM CHLORIDE 1500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| American Health Packaging | POTASSIUM CHLORIDE 20 meq/1 | Jul 15, 2026 | Sep 2, 2026 |
| American Health Packaging | POTASSIUM CHLORIDE 750 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Aurobindo Pharma Limited | POTASSIUM CHLORIDE 1500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Aurobindo Pharma Limited | POTASSIUM CHLORIDE 750 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Aurobindo Pharma Limited | POTASSIUM CHLORIDE 1125 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| AvKARE | POTASSIUM CHLORIDE 750 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| AvKARE | POTASSIUM CHLORIDE 1500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Camber Pharmaceuticals, Inc. | POTASSIUM CHLORIDE 750 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Camber Pharmaceuticals, Inc. | POTASSIUM CHLORIDE 1500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Camber Pharmaceuticals, Inc. | POTASSIUM CHLORIDE 1125 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Cardinal Health 107, LLC | POTASSIUM CHLORIDE 1500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Direct_Rx | POTASSIUM CHLORIDE 750 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Glenmark Pharmaceuticals Inc., USA | POTASSIUM CHLORIDE 1500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Granules Pharmaceuticals Inc. | POTASSIUM CHLORIDE 600 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Granules Pharmaceuticals Inc. | POTASSIUM CHLORIDE 750 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Lupin Pharmaceuticals,Inc. | POTASSIUM CHLORIDE 10 meq/1 | Jul 15, 2026 | Sep 2, 2026 |
| Lupin Pharmaceuticals,Inc. | POTASSIUM CHLORIDE 20 meq/1 | Jul 15, 2026 | Sep 2, 2026 |
| Major Pharmaceuticals | POTASSIUM CHLORIDE 20 meq/1 | Jul 15, 2026 | Sep 2, 2026 |
| Major Pharmaceuticals | POTASSIUM CHLORIDE 750 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Major Pharmaceuticals | POTASSIUM CHLORIDE 1500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Mckesson Corporation DBA SKY Packaginng | POTASSIUM CHLORIDE 750 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Northstar Rx LLC | POTASSIUM CHLORIDE 750 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Northstar Rx LLC | POTASSIUM CHLORIDE 1500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Northwind Health Company, LLC | POTASSIUM CHLORIDE 1500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| PD-Rx Pharmaceuticals, Inc. | POTASSIUM CHLORIDE 20 meq/1 | Jul 15, 2026 | Sep 2, 2026 |
| Proficient Rx LP | POTASSIUM CHLORIDE 1500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Proficient Rx LP | POTASSIUM CHLORIDE 20 meq/1 | Jul 15, 2026 | Sep 2, 2026 |
| Rising Pharma Holdings, Inc. | POTASSIUM CHLORIDE 750 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Potassium Chloride — NDC 68382-0740-01," retrieved September 3, 2026, https://drugdashboards.com/drug/68382074001.
Free to cite with attribution — see how the data is put together.